BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 29719282)

  • 1. Intravenously Delivered Allogeneic Mesenchymal Stem Cells Bidirectionally Regulate Inflammation and Induce Neurotrophic Effects in Distal Middle Cerebral Artery Occlusion Rats Within the First 7 Days After Stroke.
    Li X; Huang M; Zhao R; Zhao C; Liu Y; Zou H; Chen L; Guan Y; Zhang YA
    Cell Physiol Biochem; 2018; 46(5):1951-1970. PubMed ID: 29719282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparsion between Intravenous Delivered Human Fetal Bone Marrow Mesenchymal Stromal Cells and Mononuclear Cells in the Treatment of Rat Cerebral Infarct.
    Huang AH; Zhang PP; Zhang B; Ma BQ; Guan YQ; Zhou YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):497-506. PubMed ID: 27825404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model.
    Wakabayashi K; Nagai A; Sheikh AM; Shiota Y; Narantuya D; Watanabe T; Masuda J; Kobayashi S; Kim SU; Yamaguchi S
    J Neurosci Res; 2010 Apr; 88(5):1017-25. PubMed ID: 19885863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow-mesenchymal stem cells modulate microglial activation in the peri-infarct area in rats during the acute phase of stroke.
    Li Z; Ye H; Cai X; Sun W; He B; Yang Z; Xu P
    Brain Res Bull; 2019 Nov; 153():324-333. PubMed ID: 31589902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow mesenchymal stem cell transplantation downregulates plasma level and the microglia expression of transforming growth factor β1 in the acute phase of cerebral cortex ischemia.
    Liang ZH; Gu JJ; Yu WX; Guan YQ; Khater M; Li XB
    Chronic Dis Transl Med; 2020 Dec; 6(4):270-280. PubMed ID: 33336172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dose of Intravenously Transplanted Bone Marrow Stromal Cells Determines the Therapeutic Effect on Vascular Remodeling in a Rat Model of Ischemic Stroke.
    He B; Yao Q; Liang Z; Lin J; Xie Y; Li S; Wu G; Yang Z; Xu P
    Cell Transplant; 2016 Dec; 25(12):2173-2185. PubMed ID: 27480476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated brain derived neurotrophic factor levels in plasma reflect in vivo functional viability of infused mesenchymal stem cells for stroke in rats.
    Nakamura H; Sasaki Y; Sasaki M; Kataoka-Sasaki Y; Oka S; Nakazaki M; Namioka T; Namioka A; Onodera R; Suzuki J; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O
    J Neurosurg Sci; 2019 Feb; 63(1):42-49. PubMed ID: 28181779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid-pretreated Wharton's jelly mesenchymal stem cells in combination with triiodothyronine improve expression of neurotrophic factors in the subventricular zone of the rat ischemic brain injury.
    Sabbaghziarani F; Mortezaee K; Akbari M; Kashani IR; Soleimani M; Moini A; Ataeinejad N; Zendedel A; Hassanzadeh G
    Metab Brain Dis; 2017 Feb; 32(1):185-193. PubMed ID: 27549229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke.
    van Velthoven CT; Sheldon RA; Kavelaars A; Derugin N; Vexler ZS; Willemen HL; Maas M; Heijnen CJ; Ferriero DM
    Stroke; 2013 May; 44(5):1426-32. PubMed ID: 23539530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of differentiated bone marrow stromal cells promotes motor functional recovery in rats with stroke.
    Huang W; Mo X; Qin C; Zheng J; Liang Z; Zhang C
    Neurol Res; 2013 Apr; 35(3):320-8. PubMed ID: 23485057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in host blood factors and brain glia accompanying the functional recovery after systemic administration of bone marrow stem cells in ischemic stroke rats.
    Yang M; Wei X; Li J; Heine LA; Rosenwasser R; Iacovitti L
    Cell Transplant; 2010; 19(9):1073-84. PubMed ID: 20412636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic efficacy of lentiviral vector mediated BDNF gene-modified MSCs in cerebral infarction].
    Huang D; Zhang Z; Chen B; Wu X; Wang N; Zhang Y
    Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1174-9. PubMed ID: 18837391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraarterially delivered human umbilical cord blood-derived mesenchymal stem cells in canine cerebral ischemia.
    Chung DJ; Choi CB; Lee SH; Kang EH; Lee JH; Hwang SH; Han H; Lee JH; Choe BY; Lee SY; Kim HY
    J Neurosci Res; 2009 Dec; 87(16):3554-67. PubMed ID: 19642203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats.
    Bao X; Wei J; Feng M; Lu S; Li G; Dou W; Ma W; Ma S; An Y; Qin C; Zhao RC; Wang R
    Brain Res; 2011 Jan; 1367():103-13. PubMed ID: 20977892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human umbilical cord derived mesenchymal stem cells overexpressing HO-1 attenuate neural injury and enhance functional recovery by inhibiting inflammation in stroke mice.
    Yang Y; Liu Q; Deng S; Shao Q; Peng L; Ling Y; Huang Y; Zheng S; Jiang Q; Nie D; Chen J
    CNS Neurosci Ther; 2024 Feb; 30(2):e14412. PubMed ID: 37592866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological effects of the intraparenchymal administration of allogeneic and autologous adipose-derived mesenchymal stem cells after the acute phase of middle cerebral artery occlusion in rats.
    Yu Z; Wenyan T; Xuewen S; Baixiang D; Qian W; Zhaoyan W; Yinxiang Y; Suqing Q; Zuo L
    J Transl Med; 2018 Dec; 16(1):339. PubMed ID: 30518375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model.
    Kurozumi K; Nakamura K; Tamiya T; Kawano Y; Kobune M; Hirai S; Uchida H; Sasaki K; Ito Y; Kato K; Honmou O; Houkin K; Date I; Hamada H
    Mol Ther; 2004 Feb; 9(2):189-97. PubMed ID: 14759803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic therapeutic effects of intracerebral transplantation of human modified bone marrow-derived stromal cells (SB623) and voluntary exercise with running wheel in a rat model of ischemic stroke.
    Yabuno S; Yasuhara T; Nagase T; Kawauchi S; Sugahara C; Okazaki Y; Hosomoto K; Sasada S; Sasaki T; Tajiri N; Borlongan CV; Date I
    Stem Cell Res Ther; 2023 Jan; 14(1):10. PubMed ID: 36691091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cell transplantation modulates neuroinflammation in focal cerebral ischemia: contribution of fractalkine and IL-5.
    Sheikh AM; Nagai A; Wakabayashi K; Narantuya D; Kobayashi S; Yamaguchi S; Kim SU
    Neurobiol Dis; 2011 Mar; 41(3):717-24. PubMed ID: 21168500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Mesenchymal Stem Cell Treatment on the Expression of Matrix Metalloproteinases and Angiogenesis during Ischemic Stroke Recovery.
    Nam HS; Kwon I; Lee BH; Kim H; Kim J; An S; Lee OH; Lee PH; Kim HO; Namgoong H; Kim YD; Heo JH
    PLoS One; 2015; 10(12):e0144218. PubMed ID: 26637168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.